Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Medical Hypotheses|March 14, 2007
Pellagra: A clue as to why energy failure causes diseases?Adrian C Williams, David B RamsdenJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 11, 2005
Autotoxicity, methylation and a road to the prevention of Parkinson's diseaseAdrian C Williams, David B RamsdenCurrent Gerontology and Geriatrics Research|April 27, 2012
Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from PellagraAdrian C Williams, Lisa J Hill, David B RamsdenJournal of Biochemical and Molecular Toxicology|July 23, 2013
Neuroprotective effects of nicotinamide N-methyltransferase and its metabolite 1-methylnicotinamideZeinab H Milani, David B Ramsden, Richard B ParsonsJournal of Biochemical and Molecular Toxicology|January 8, 2020
Nicotinamide N-methyltransferase expression in SH-SY5Y human neuroblastoma cells decreases oxidative stressRakhee J Mistry, Fábio Klamt, David B Ramsden, et al.International Journal of Tryptophan Research : IJTR|February 21, 2022
Nicotinamide N-Methyltransferase in Health and CancerDavid B Ramsden, Rosemary H Waring, David J Barlow, et al.Clinical Laboratory|September 8, 2017
Serum IgG4 Concentration in IgG4-Related DiseaseShigeyuki Kawa, Markus Skold, David B Ramsden, et al.Neuroscience Letters|May 3, 2003
High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's diseaseRichard B Parsons, Stuart W Smith, Rosemary H Waring, et al.Expert Review of Endocrinology & Metabolism|August 1, 2018
Human amylase gene copy number variation as a determinant of metabolic statePatrick J D Elder, David B Ramsden, David Burnett, et al.Journal of Neuropathology and Experimental Neurology|February 21, 2002
Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brainRichard B Parsons, Marie-Louise Smith, Adrian C Williams, et al.Pageof 4